ZEPP
Zepp Health Corporation
There isn't enough reported data to score ZEPP yet.
ZEPP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Healthy |
ZEPP's balance sheet is currently healthy, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
ZEPP PE Valuation
ZEPP has no meaningful PE right now: it lost money over the past year.
ZEPP Forward outlook
There aren't enough analyst estimates for ZEPP to show an outlook.
ZEPP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.16 | +$0.13 |
| Q4 2024 | -$0.29 | +$0.23 |
| Q4 2023 | -$0.52 | +$0.18 |
| Q4 2022 | -$0.70 | -326% |
| Q4 2021 | $0.31 | -42% |
| Q4 2020 | $0.53 | -60% |
| Q4 2019 | $1.34 | +332% |
| Q4 2018 | $0.31 | -21% |
ZEPP has swung to a loss: it lost $0.16 per share over the past year, after a profit the year before.
ZEPP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $258.9M | +42% |
| Q4 2024 | $182.6M | -51% |
| Q4 2023 | $374.5M | -40% |
| Q4 2022 | $621.7M | -34% |
| Q4 2021 | $938M | -2.8% |
| Q4 2020 | $965.5M | +11% |
| Q4 2019 | $872.3M | +59% |
| Q4 2018 | $547.1M | +78% |
ZEPP's revenue has slid since its 2020 peak: $259M last quarter, down 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -11% | -13 points |
| Q4 2024 | -26% | -29 points |
| Q4 2023 | -8.3% | -19 points |
| Q4 2022 | -9.9% | -20 points |
| Q4 2021 | 1.5% | -7.4 points |
| Q4 2020 | 2.7% | -4.3 points |
| Q4 2019 | 10% | +11 points |
| Q4 2018 | 10% | N/A |
ZEPP's operating margin was −11% last quarter, down 13 points from the same quarter a year ago, near the bottom of its range since 2016.
ZEPP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$26.2M | -$413K |
| Q4 2024 | -$25.8M | -160% |
| Q4 2023 | $43.1M | +$162.6M |
| Q4 2022 | -$119.4M | -$77.6M |
| Q4 2021 | -$41.8M | -478% |
| Q4 2020 | $11.1M | -81% |
| Q4 2019 | $59.1M | -43% |
| Q4 2018 | $103.6M | +218% |
ZEPP's free cash flow was −$128M over the past year, against $132M the year before.
ZEPP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -4.4M shares |
| 1 year | +285% | +188M shares |
ZEPP has 254M diluted shares, up 285% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $1.2M |
| Q4 2024 | $2.3M |
| Q4 2023 | $2.7M |
| Q4 2022 | $8M |
| Q4 2021 | $2.1M |
| Q4 2018 | $1.2M |
| Q4 2016 | — |
ZEPP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -5.1x | Net Cash |
| Q4 2020 | -11.0x | Net Cash |
| Q4 2019 | -2.9x | Net Cash |
| Q4 2018 | -3.8x | Net Cash |
| Q4 2017 | -1.9x | Net Cash |
ZEPP has more cash than debt.
ZEPP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.6 | Oversold |
| Stochastic | 4.5 | Oversold |
ZEPP's weekly RSI is 30 (oversold) and its Stochastic is 4 (oversold).
ZEPP PE vs Technology Sector
| Metric | ZEPP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
ZEPP has no meaningful PE right now: it lost money over the past year.
ZEPP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.03 | 17% below |
| 20 week MA | $4.18 | 40% below |
| 50 week MA | $11.9 | 79% below |
| 100 week MA | $14.0 | 82% below |
| 200 week MA | $9.23 | 73% below |
ZEPP is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
ZEPP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.9 | $47.9 | -0.1% |
| 2021 | $47.9 | $20.7 | -57% |
| 2022 | $20.7 | $6.00 | -71% |
| 2023 | $6.00 | $5.68 | -5.3% |
| 2024 | $5.68 | $2.78 | -51% |
| 2025 | $2.78 | $28.3 | +917% |
| 2026 YTD | $28.3 | $2.51 | -91% |
ZEPP's yearly returns have swung widely, from +917% in 2025 to −71% in 2022. It's down 91% so far in 2026.